The use of self-organizing maps to study fatty acids in neuropsychiatric disorders

The use of self-organizing maps to study fatty acids in neuropsychiatric disorders

Bibliographic Details
Main Authors:	Cappello Glenda, Tonello Luciano, Cocchi Massimo
Format:	Article
Language:	English
Published:	BMC 2008-04-01
Series:	Annals of General Psychiatry

Similar Items

The use of artificial neural networks to study fatty acids in neuropsychiatric disorders
by: Tonello Lucio, et al.
Published: (2008-04-01)

Fatty acids and oxidative stress in psychiatric disorders
by: Tonello Lucio, et al.
Published: (2008-04-01)

Fatty acids and neuropsychiatric disorders
by: Puri Basant K
Published: (2008-04-01)

Fatty acids, membrane viscosity, serotonin and ischemic heart disease
by: Cocchi Massimo, et al.
Published: (2010-09-01)

Biological, biochemical and mathematical considerations about the use of an Artificial Neural Network (ANN) for the study of the connection between platelet fatty acids and major depression. Technical report
by: M. Cocchi, et al.
Published: (2006-01-01)

The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders
by: Arne Reimers, et al.
Published: (2019-06-01)

Linoleic acid: Is this the key that unlocks the quantum brain? Insights linking broken symmetries in molecular biology, mood disorders and personalistic emergentism
by: Massimo Cocchi, et al.
Published: (2017-04-01)

Polyunsaturated fatty acid deficiency and pediatric neuropsychiatric morbidity
by: O. V. Bykova, et al.
Published: (2020-11-01)

The gastrointestinal-brain axis in humans as an evolutionary advance of the root-leaf axis in plants: A hypothesis linking quantum effects of light to serotonin and auxin
by: Lucio Tonello, Bekim Gashi, Alessandro Scuotto, Glenda Cappello, Massimo Cocchi, Fabio Gabrielli, Jack A. Tuszynski
Published: (2018-05-01)

The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders
by: Simona Dedoni, et al.
Published: (2024-03-01)

Reelin and neuropsychiatric disorders
by: Kazuhiro Ishii, et al.
Published: (2016-10-01)

Mapping Molecular Changes in Human Neuropsychiatric Disorders to Zebrafish Behavioral Profiles
by: Stein, Daniel J.
Published: (2022)

Molecular contiguity between man and animal: the cutting-edge studies carried out by Paolo Sotgiu Institute, L.U.de.S. University, Lugano, Switzerland
by: Massimo Cocchi, et al.
Published: (2014-01-01)

An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders
by: Nicolás Lamanna-Rama, et al.
Published: (2022-02-01)

Gut Bacteria and Neuropsychiatric Disorders
by: Leon M. T. Dicks, et al.
Published: (2021-12-01)

The Histaminergic System in Neuropsychiatric Disorders
by: Li Cheng, et al.
Published: (2021-09-01)

MODELING OF CHILDHOOD NEUROPSYCHIATRIC DISORDERS
by: Flora Vaccarino
Published: (2023-10-01)

Editorial: The heterogeneity of neuropsychiatric disorders
by: Zhao-Min Wu, et al.
Published: (2023-01-01)

Perinatal Programming of Neuropsychiatric Disorders
by: Li-Tung Huang
Published: (2011-06-01)

Gut microbiome in neuropsychiatric disorders
by: Diana Marcela MEJÍA-GRANADOS, et al.
Published: (2022-03-01)

NEUROPSYCHIATRIC DISORDERS IN CUSHING’S SYNDROME
by: Rosario ePivonello, et al.
Published: (2015-04-01)

Epigenetic Regulations in Neuropsychiatric Disorders
by: Janise N. Kuehner, et al.
Published: (2019-04-01)

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
by: Martina Giacalone, et al.
Published: (2021-10-01)

The current "next step" in neuropsychiatric disorders studies
by: Lombroso Paul J., et al.
Published: (2002-01-01)

Neurological and neuropsychiatric comorbidities occurring in fatty liver diseases
by: I. M. Balmus, et al.
Published: (2023-03-01)

Poly-Unsaturated Fatty Acids in ADHD and in Other Neuropsychiatric Conditions: A Multiple Case Presentation
by: Matteo Chiappedi
Published: (2021-05-01)

Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders
by: Sen Zhang, et al.
Published: (2023-11-01)

Tibetan medicinal formulas used to treat neuropsychiatric disorders
by: Raquel de Luna Antonio, et al.
Published: (2012-06-01)

Oestrogens, brain function and neuropsychiatric disorders
by: Craig, M, et al.
Published: (2004)

Oestrogen, brain function, and neuropsychiatric disorders.
by: Cutter, W, et al.
Published: (2003)

Postmortem brain collections for neuropsychiatric disorders
by: Harrison, P, et al.
Published: (2005)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
by: Yao Shen, et al.
Published: (2022-08-01)

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
by: Amjad H. Bazzari, et al.
Published: (2022-07-01)

Copy Number Variations in Neuropsychiatric Disorders
by: Gergely Büki, et al.
Published: (2023-09-01)

Noteworthy perspectives on microglia in neuropsychiatric disorders
by: Hongrui Zhu, et al.
Published: (2023-10-01)

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
by: Majid Davidson, et al.
Published: (2022-09-01)

Impact of COVID-19 on Neuropsychiatric Disorders
by: Niloufar Zia, et al.
Published: (2022-09-01)

Neuropsychiatric disorders correction in Alzheimer's disease
by: N. N. Koberskaya
Published: (2022-06-01)

Cognitive and neuropsychiatric disorders in extrapyramidal diseases
by: O. S. Levin, et al.
Published: (2014-01-01)

MICROBIOME: THE MISSING LINK IN NEUROPSYCHIATRIC DISORDERS
by: Alper Evrensel, et al.
Published: (2017-01-01)